TY - JOUR
T1 - The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product
AU - Beom, Sik Kang
AU - Cooper, David R.
AU - Devedjiev, Yancho
AU - Derewenda, Urszula
AU - Derewenda, Zygmunt S.
PY - 2002
Y1 - 2002
N2 - Neurofibromatosis type 2 is an autosomal dominant disorder characterized by central nervous system tumors. The cause of the disease has been traced to mutations in the gene coding for a protein that is alternately called merlin or schwannomin and is a member of the ERM family (ezrin, radixin and moesin). The ERM proteins link the cytoskeleton to the cell membrane either directly through integral membrane proteins or indirectly through membrane-associated proteins. In this paper, the expression, purification, crystallization and crystal structure of the N-terminal domain of merlin are described. The crystals exhibit the symmetry of space group P212121, with two molecules in the asymmetric unit. The recorded diffraction pattern extends to 1.8 Å resolution. The structure was solved by the molecular-replacement method and the model was refined to a conventional R value of 19.3% (Rfree = 22.7%). The N-terminal domain of merlin closely resembles those described for the corresponding domains in moesin and radixin and exhibits a cloverleaf architecture with three distinct subdomains. The structure allows a better rationalization of the impact of selected disease-causing mutations on the integrity of the protein.
AB - Neurofibromatosis type 2 is an autosomal dominant disorder characterized by central nervous system tumors. The cause of the disease has been traced to mutations in the gene coding for a protein that is alternately called merlin or schwannomin and is a member of the ERM family (ezrin, radixin and moesin). The ERM proteins link the cytoskeleton to the cell membrane either directly through integral membrane proteins or indirectly through membrane-associated proteins. In this paper, the expression, purification, crystallization and crystal structure of the N-terminal domain of merlin are described. The crystals exhibit the symmetry of space group P212121, with two molecules in the asymmetric unit. The recorded diffraction pattern extends to 1.8 Å resolution. The structure was solved by the molecular-replacement method and the model was refined to a conventional R value of 19.3% (Rfree = 22.7%). The N-terminal domain of merlin closely resembles those described for the corresponding domains in moesin and radixin and exhibits a cloverleaf architecture with three distinct subdomains. The structure allows a better rationalization of the impact of selected disease-causing mutations on the integrity of the protein.
UR - http://www.scopus.com/inward/record.url?scp=0036128427&partnerID=8YFLogxK
U2 - 10.1107/S0907444901021175
DO - 10.1107/S0907444901021175
M3 - Article
C2 - 11856822
AN - SCOPUS:0036128427
SN - 0907-4449
VL - 58
SP - 381
EP - 391
JO - Acta Crystallographica Section D: Biological Crystallography
JF - Acta Crystallographica Section D: Biological Crystallography
IS - 3
ER -